<DOC>
	<DOCNO>NCT00839852</DOCNO>
	<brief_summary>This outpatient study evaluate long-term safety , tolerability , pharmacokinetics cariprazine patient Schizophrenia .</brief_summary>
	<brief_title>The Purpose Study Determine Whether Cariprazine Safe Tolerated Long-term Treatment Patients With Chronic Stable Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients complete doubleblind treatment period leadin study ( RGHMD16 ) Patients respond doubleblind treatment leadin study outpatient ( least 20 % reduction relative Visit 2 leadin study PANSS total score CGIS le equal 3 Patients eligible continue outpatient base opinion Principal Investigator Patients must caregiver ensure treatment compliance Patients clinically significant abnormality physical examination , laboratory , vital sign , and/ ECG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>61 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>